{"id":16040,"date":"2025-09-19T20:30:04","date_gmt":"2025-09-19T17:30:04","guid":{"rendered":"https:\/\/testsunucusu.com\/acibadem\/doctor\/aziz-yazar\/"},"modified":"2025-12-11T17:55:47","modified_gmt":"2025-12-11T14:55:47","slug":"aziz-yazar","status":"publish","type":"idel_doctor","link":"https:\/\/acibademinternational.com\/doctor\/aziz-yazar\/","title":{"rendered":"Aziz Yazar"},"content":{"rendered":"

<\/p>\n

\n

Prof. Aziz Yazar<\/strong> is a medical doctor trained at Ac\u0131badem University Faculty of Medicine, graduating in 2010. Since 2007 he has been affiliated with Ac\u0131badem Health Group, where he has contributed to clinical care and patient-focused services. He is an active member of the Turkish Oncology Society and the Istanbul Medical Chamber, reflecting his commitment to professional development and quality practice in oncology and medicine. Known for a patient-centered approach and collaborative teamwork, he combines solid clinical training with ongoing involvement in professional organizations.<\/p>\n

<\/div>\n

Education<\/strong><\/p>\n

    \n
  • 2010<\/span> Acibadem University Faculty of Medicine<\/span><\/li>\n
  • 2005<\/span> Istanbul University Oncology Institute Medical Oncology<\/span><\/li>\n
  • 2004<\/span> Istanbul University Institute of Oncology \/ Associate Professor<\/span><\/li>\n
  • 1997<\/span> Istanbul University Istanbul Faculty of Medicine Internal Medicine<\/span><\/li>\n
  • 1986 \u2013 1993<\/span> Hacettepe University Faculty of Medicine<\/span><\/li>\n<\/ul>\n

    Experience<\/strong><\/p>\n

      \n
    • 2007<\/span> Acibadem Health Group<\/span><\/li>\n
    • 2005 \u2013 2007<\/span> American Hospital<\/span><\/li>\n
    • 2002 \u2013 2005<\/span> Istanbul University Oncology Institute \/ Medical Oncology<\/span><\/li>\n
    • 1999 \u2013 2002<\/span> Mersin University Faculty of Medicine<\/span><\/li>\n
    • 1993 \u2013 1998<\/span> Istanbul University Istanbul Faculty of Medicine<\/span><\/li>\n<\/ul>\n

      Memberships<\/strong><\/p>\n

        \n
      • Turkish Oncology Society<\/span><\/li>\n
      • Istanbul Medical Chamber<\/span><\/li>\n<\/ul>\n

        Publications<\/strong><\/p>\n

          \n
        • Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients.<\/strong>
          \nMedical Oncology, 25, 394-399 (2008) \u00dcst\u00fcner Z, Saip P, Yasasever V, Vural B, Yazar A, Bal C, \u00d6zt\u00fcrk B, \u00d6zbek U, Topuz E.<\/li>\n
        • The role of serum vascular endothelial growth factor and matrix metalloproteinase-9 in predicting response to chemotherapy and prognosis in patients with advanced non-small cell lung carcinoma.<\/strong>
          \nSouthern Medical Journal, 101, 327-328 (2008) Yazar A, Soydin\u00e7 H, Ertan E, Yasasever V, Ta\u015f F,<\/li>\n
        • Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: A phase II study.<\/strong>
          \nLung Cancer, 58, 246-252 (2007) Ayd\u0131ner A, K\u0131y\u0131k M, \u00c7\u0131kr\u0131k\u00e7\u0131o\u011flu S, Ko\u015far F, G\u00fcrses A, Turna A, Yazar A, Dilege \u015e, G\u00f6ksel T, \u00c7akan A.<\/li>\n
        • Serum vascular endothelial growth factor and Bcl-2 levels and their relationship in stage IV non-small cell lung cancer.<\/strong>
          \nTurkish Journal of Oncology, 22, 76-81 (2007) Yazar E, Soydin\u00e7 H, Yazar A, \u00d6zg\u00fcl A, Ta\u015f F, Yasasever V, \u00c7aml\u0131ca H, Y\u0131lmaz V.<\/li>\n
        • Prevalence of irritable bowel syndrome in bronchial asthma patients.<\/strong>
          \nRespiration, 8, 151-155 (2006). Ertan E, Ozgul MA, Yildiz P, Kadakal F, Camlica H, Yazar A, Yilmaz V.<\/li>\n
        • Is lower socio-economic status a risk factor for Helicobacter pylori infection in pregnant women with hyperemesis gravidarum.<\/strong>
          \nTurk J Gastroenterol, 15, 86-89 (2004) Karaca \u00c7, G\u00fcler N, Yazar A, \u00c7aml\u0131ca H, Demir K, Y\u0131ld\u0131r\u0131m G.<\/li>\n
        • Prognostic factors for survival in metastatic renal cell carcinoma: Experience from a single institution.<\/strong>
          \nThirty-Ninth Annual Meeting of American Society of Clinical Oncology, 1750, Chicago, USA, 2003 Bavbek SE, Yazar A, Ba\u015faran M, Onat H,<\/li>\n
        • Lipid peroxidation and antioxidant levels in hyperthyroidism.<\/strong>
          \nCumhuriyet University Medical Faculty Journal, 22, 196-200 (2000) Akbay E, Tamer L, Konca K, Pata C, Yazar A.<\/li>\n
        • A case of Stevens-Johnson syndrome associated with cephazoline and paracetamol.<\/strong>
          \nJournal of Mersin University Faculty of Medicine, 1, 91-94 (2000) Konca K, K\u00f6kt\u00fcrk A, Akbay E, Pata C, Yazar A,<\/li>\n<\/ul>\n<\/div>\n","protected":false},"featured_media":16041,"template":"","categories":[14,4,842],"class_list":["post-16040","idel_doctor","type-idel_doctor","status-publish","has-post-thumbnail","hentry","category-altunizade-hospital","category-doctors","category-oncology"],"_links":{"self":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/idel_doctor\/16040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/idel_doctor"}],"about":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/types\/idel_doctor"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/media\/16041"}],"wp:attachment":[{"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/media?parent=16040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/acibademinternational.com\/wp-json\/wp\/v2\/categories?post=16040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}